
The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.

The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.

Colleen Kelley, MD, MPH, describes the current state of HIV vaccine efforts.

A new study demonstrates that the introduction of a universal immunization program had positive impact on the educational attainment of people in India’s school system.

A study has identified geographic and socioeconomic drivers of conscientious vaccine exemption choice in Texas.

The investigators of a new observational cohort study on incidence of tetanus and diphtheria in 31 countries have provided data that suggest no benefit associated with performing adult booster vaccinations.

Measles leave every organ system vulnerable and can lead to a wide range of serious complications, including hepatitis, appendicitis and viral meningitis, according to a new study.

A small but significant percentage of Americans believe common misconceptions about vaccines, and that misinformation was associated with social media use and lower trust of medical experts, a new study found.

Based on data from 4112 children and adults, vaccine effectiveness was estimated to be 37% against influenza A and 50% against influenza B viruses.

Pneumococcal conjugate vaccines have been effective at reducing pneumonia, sepsis, and bacteremia in immunized populations. Pneumococcal meningitis, however, remains a significant challenge.

A new study found that the Zoster Vaccine Live not only reduced the risk for shingles but also reduced stroke risk by 16% in older adults.

There could be viable options within a few months, but will it be in time to contain an outbreak?

The US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices has released the 2020 Recommended Immunization Schedule for adults.

In this episode, our guests compare the West African Ebola outbreak to the ongoing outbreak in the Democratic Republic of the Congo.

The CDC’s Advisory Committee on Immunization Practices have updated vaccine recommendations to allow interchangeable use of Tdap and Td in some cases.

A new study provides evidence that there was no change in herd immunity among more than 34,000 students in Australia with moderate to high vaccination rates.

A study comparing immunogenicity, safety, and interchangeability of JENVAC to an SA 14-14-2 strain derived vaccine has found JENVAC offers statistically higher immunological measures.

Despite children’s higher risk of complications from influenza, few US child care centers report influenza vaccine requirements for children and/or adult care workers.

Pharmacists have the opportunity to take a lead role in providing education on the importance of vaccines in protecting people from preventable illnesses, according to a session which took place at the American Society of Health-System Pharmacists (ASHP) 54th Midyear Clinical Meeting & Exhibition.

Combining financial incentives and accelerated vaccine schedules may improve hepatitis B vaccination completion among people who inject drugs who are at high risk for the infection, according to a new study.

The MMWR contains new recommendations pertaining to large scale emergency response protocols.

Global efforts to eliminate measles took a step backward, with the number of cases rising to 353,236 in 2018, up 167% from 132,413 cases in 2016.

Incorporating a signaling protein known as B cell activating factor into the rabies vaccine improved speed and strength of the antibody responses, investigators at Thomas Jefferson University found.

A new study examines the association between vaccine-preventable disease incidence and state vaccine exemption legislation.

The vaccine candidate, TAK-003, is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all 4 serotypes.

Modified vaccinia Ankara vaccination showed efficacy protecting against smallpox in a phase 3 clinical trial, with fewer adverse events reported compared to the ACAM2000 vaccine group.